Display options
Share it on

Biomicrofluidics. 2013 Aug 26;7(4):44126. doi: 10.1063/1.4818838. eCollection 2013.

Discrimination between the human prostate normal cell and cancer cell by using a novel electrical impedance spectroscopy controlling the cross-sectional area of a microfluidic channel.

Biomicrofluidics

Giseok Kang, Young-Jae Kim, Hong-Sang Moon, Jeong-Woo Lee, Tag-Keun Yoo, Kwangsung Park, Jong-Hyun Lee

Affiliations

  1. Department of Medical System Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju 500-712, South Korea.
  2. Department of Electrical and Computer Engineering, College of Engineering, Seoul National University, Seoul 151-744, South Korea.
  3. Department of Urology, College of Medicine, Hanyang University, Guri 471-701, South Korea.
  4. Department of Urology, Eulji Medical Center, Eulji University School of Medicine, Seoul 139-872, South Korea.
  5. Department of Urology, Chonnam National University Medical School, Gwangju 501-757, South Korea.
  6. Department of Medical System Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju 500-712, South Korea ; Department of Mechatronics, Gwangju Institute of Science and Technology (GIST), Gwangju 500-712, South Korea.

PMID: 24404059 PMCID: PMC3772938 DOI: 10.1063/1.4818838

Abstract

The prostate biopsy method shows a high false negative result because the suspicious tissue considered as cancer is not confirmed during tissue sampling. Thus, repeated biopsy procedures and diagnostic errors in relation to prostate cancer frequently occur. The purpose of this research is to enhance the prostate cancer detection rate by using microfluidic electrical impedance spectroscopy (μEIS), which allows real-time measurement of the electrical impedance of a single human prostate normal cell and cancer cell. The μEIS was equipped with a movable flexible membrane, which is operated by pneumatic pressure to capture the single cell on the surface of sensing electrodes. The forced tight contact between the cell and electrodes makes it possible to measure the electrical characteristics of the cell with a high sensitivity. The μEIS discriminates well between normal human prostate cells (RWPE-1) and cancer cells (PC-3) at 8.7 kHz based on the electrical signal responses of the cells. The average difference rates of admittance magnitude and susceptance are 54.55% and 54.59%, respectively. The developed μEIS also shows high repeatability, which was verified by a deionized water test conducted before and after each cell assay; the maximum variance of both the impedance and admittance at 8.7 kHz was as small as 9.48%.

References

  1. Biomicrofluidics. 2012 Jul 13;6(3):34103 - PubMed
  2. Biomicrofluidics. 2011 Mar 30;5(1):14113 - PubMed
  3. J Urol. 1994 May;151(5):1283-90 - PubMed
  4. Biophys J. 1999 Jun;76(6):3307-14 - PubMed
  5. Mol Nutr Food Res. 2009 Feb;53(2):171-84 - PubMed
  6. Eur Urol. 2013 Feb;63(2):214-30 - PubMed
  7. J Biomech. 2005 Jan;38(1):117-24 - PubMed
  8. Biomicrofluidics. 2013 Jun 05;7(3):34108 - PubMed
  9. J Urol. 2007 Jul;178(1):88-92 - PubMed
  10. Analyst. 2008 Oct;133(10):1432-9 - PubMed
  11. Ann Intern Med. 1999 Jun 15;130(12):995-1004 - PubMed
  12. Biomicrofluidics. 2012 Aug 13;6(3):34112 - PubMed
  13. Biomicrofluidics. 2007 Nov 30;1(4):44103 - PubMed
  14. Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7896-900 - PubMed
  15. J Biomech Eng. 2010 Oct;132(10):104501 - PubMed
  16. Curr Urol Rep. 2013 Jun;14(3):209-13 - PubMed
  17. J Urol. 2002 Jun;167(6):2435-9 - PubMed
  18. J Urol. 2012 Apr;187(4):1511-2 - PubMed
  19. Clin Cancer Res. 2007 Jan 1;13(1):139-43 - PubMed

Publication Types